1996
Cyclic vomiting: association with multiple homeostatic abnormalities and response to ketorolac.
Pasricha P, Schuster M, Saudek C, Wand G, Ravich W. Cyclic vomiting: association with multiple homeostatic abnormalities and response to ketorolac. The American Journal Of Gastroenterology 1996, 91: 2228-32. PMID: 8855755.Peer-Reviewed Original ResearchConceptsEndogenous prostaglandin releaseTrial of erythromycinEpisodes of vomitingHigh-dose dexamethasoneSerum adrenocorticotropic hormoneHypothalamic-pituitary systemMild temperature elevationInitial screening testCharacterized disordersEndocrinological testingHomeostatic abnormalitiesIntramuscular ketorolacSensory seizuresAbdominal migraineDiabetic femalesAntral motilityBlood pressureSustained reliefClinical symptomsHormonal surgesRecurrent episodesUrinary cortisolAbnormal elevationAdrenocorticotropic hormoneCyclic vomitingBotulinum toxin for achalasia: Long-term outcome and predictors of response
Pasricha P, Rai R, Ravich W, Hendrix T, Kalloo A. Botulinum toxin for achalasia: Long-term outcome and predictors of response. Gastroenterology 1996, 110: 1410-1415. PMID: 8613045, DOI: 10.1053/gast.1996.v110.pm8613045.Peer-Reviewed Original ResearchConceptsLong-term outcomesPredictors of responseMedian durationBotulinum toxinType of achalasiaThird of patientsMajority of patientsDuration of illnessDuration of responseLower esophageal sphincterEffective short-term reliefYears of ageShort-term reliefPrevious dilationLatter patientsToxin injectionVigorous achalasiaEsophageal sphincterRadiological characteristicsEffective treatmentAchalasiaPatientsSecond injectionResponse rateNineteen responders
1995
Intrasphincteric Botulinum Toxin for the Treatment of Achalasia
Pasricha P, Ravich W, Hendrix T, Sostre S, Jones B, Kalloo A. Intrasphincteric Botulinum Toxin for the Treatment of Achalasia. New England Journal Of Medicine 1995, 332: 774-778. PMID: 7862180, DOI: 10.1056/nejm199503233321203.Peer-Reviewed Original ResearchConceptsLower esophageal sphincterEsophageal sphincterBotulinum toxinPlacebo groupMean decreaseSymptom scoresTreatment groupsMean increaseDisorders of swallowingIntrasphincteric botulinum toxinDouble-blind trialTreatment of achalasiaMonths 14 patientsSerious adverse effectsSymptomatic improvementEsophageal retentionParalytic agentsScintigraphic studiesEsophageal scintigraphySphincterAchalasiaPatientsAdverse effectsPlaceboMonths
1994
Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial.
Pasricha P, Ravich W, Hendrix T, Sostre S, Jones B, Kalloo A. Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial. Annals Of Internal Medicine 1994, 121: 590-1. PMID: 8085691, DOI: 10.7326/0003-4819-121-8-199410150-00006.Peer-Reviewed Original Research
1991
Gastric antral vascular ectasia ("watermelon stomach"): radiologic findings.
Urban B, Jones B, Fishman E, Kern S, Ravich W. Gastric antral vascular ectasia ("watermelon stomach"): radiologic findings. Radiology 1991, 178: 517-8. PMID: 1987618, DOI: 10.1148/radiology.178.2.1987618.Peer-Reviewed Original Research
1987
Pharyngeal findings in 21 patients with achalasia of the esophagus
Jones B, Donner M, Rubesin S, Ravich W, Hendrix T. Pharyngeal findings in 21 patients with achalasia of the esophagus. Dysphagia 1987, 2: 87-92. PMID: 3507299, DOI: 10.1007/bf02408139.Peer-Reviewed Original Research